122 related articles for article (PubMed ID: 6537913)
21. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
[TBL] [Abstract][Full Text] [Related]
23. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
24. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
[TBL] [Abstract][Full Text] [Related]
25. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
27. [Significance of CEA determination in breast carcinoma].
Lamerz R; Pape W; von Lieven H; Ehrhart H; Leonhardt A
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1208-12. PubMed ID: 611820
[No Abstract] [Full Text] [Related]
28. Diagnostic value of total prostate specifc antigen (TPSA) in women with breast cancer in the molecular subtyping era.
Zhang L; Yu X; Zhou L; Yang Y; Liu S
J BUON; 2018; 23(5):1316-1324. PubMed ID: 30570853
[TBL] [Abstract][Full Text] [Related]
29. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
[TBL] [Abstract][Full Text] [Related]
30. Serial tests of carcinoembryonic antigen in patients with breast cancer.
Lee YT
Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246
[TBL] [Abstract][Full Text] [Related]
31. [Clinical usefulness of carcinoembryonic antigen measurement in nipple discharge as an adjunctive tool for diagnosis of breast cancer].
Nishiguchi T; Hishimoto T; Funahashi S; Takatsuka Y; Kawahara T
Rinsho Byori; 1992 Jan; 40(1):67-72. PubMed ID: 1545528
[TBL] [Abstract][Full Text] [Related]
32. Circulating CA 15-3 levels in the postsurgical follow-up of breast cancer patients and in non-malignant diseases.
Colomer R; Ruibal A; Genollá J; Rubio D; Del Campo JM; Bodi R; Salvador L
Breast Cancer Res Treat; 1989 Mar; 13(2):123-33. PubMed ID: 2730960
[TBL] [Abstract][Full Text] [Related]
33. Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.
Tjandra JJ; McLaughlin PJ; Russell IS; Collins JP; McKenzie IF
Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1633-40. PubMed ID: 3061824
[TBL] [Abstract][Full Text] [Related]
34. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.
Molina R; Zanón G; Filella X; Moreno F; Jo J; Daniels M; Latre ML; Giménez N; Pahisa J; Velasco M
Breast Cancer Res Treat; 1995; 36(1):41-8. PubMed ID: 7579505
[TBL] [Abstract][Full Text] [Related]
35. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
36. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen in gastric cancer patients.
Shimizu N; Wakatsuki T; Murakami A; Yoshioka H; Hamazoe R; Kanayama H; Maeta M; Koga S
Oncology; 1987; 44(4):240-4. PubMed ID: 3614814
[TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer.
Inaji H; Yayoi E; Maeura Y; Matsuura N; Tominaga S; Koyama H; Takatsuka Y; Mori T
Cancer; 1987 Dec; 60(12):3008-13. PubMed ID: 3677024
[TBL] [Abstract][Full Text] [Related]
39. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of CEA and ferritin assay in breast cancer: a multivariate analysis.
Gaglia P; Caldarola B; Bussone R; Potente F; Lauro D; Jayme A; Caldarola L
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1151-5. PubMed ID: 3416899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
